Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immunosuppressant
|
| gptkbp:activeIngredient |
gptkb:tacrolimus
|
| gptkbp:approvedBy |
gptkb:European_Union
gptkb:United_States 2007 (EU) |
| gptkbp:ATCCode |
L04AD02
|
| gptkbp:form |
prolonged-release capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Advagraf
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketingAuthorizationHolder |
gptkb:Astellas_Pharma
|
| gptkbp:mechanismOfAction |
immunosuppressant
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
diarrhea
headache hypertension tremor nephrotoxicity hyperglycemia |
| gptkbp:usedFor |
prevention of organ transplant rejection
treatment of organ transplant rejection |
| gptkbp:bfsParent |
gptkb:Prograf
gptkb:tacrolimus |
| gptkbp:bfsLayer |
6
|